002332 仙琚制药
已收盘 07-22 15:00:00
资讯
新帖
简况
【机构调研记录】财通基金调研仙琚制药、达梦数据等4只个股(附名单)
证券之星 · 07-22 08:02
【机构调研记录】财通基金调研仙琚制药、达梦数据等4只个股(附名单)
【机构调研记录】富国基金刘莉莉调研仙琚制药
证券之星 · 07-22 08:02
【机构调研记录】富国基金刘莉莉调研仙琚制药
仙琚制药:7月17日接受机构调研,财通基金、富国基金等多家机构参与
证券之星 · 07-19
仙琚制药:7月17日接受机构调研,财通基金、富国基金等多家机构参与
仙琚制药:截止近期,公司股东人数为2万5千余人
证券之星 · 07-15
仙琚制药:截止近期,公司股东人数为2万5千余人
仙琚制药(002332)7月8日主力资金净买入2255.83万元
证券之星 · 07-09
仙琚制药(002332)7月8日主力资金净买入2255.83万元
仙琚制药(002332)7月5日主力资金净买入825.38万元
证券之星 · 07-08
仙琚制药(002332)7月5日主力资金净买入825.38万元
7月5日仙琚制药(002332)龙虎榜数据:机构净买入915.63万元,北向资金净卖出536.35万元
证券之星 · 07-05
7月5日仙琚制药(002332)龙虎榜数据:机构净买入915.63万元,北向资金净卖出536.35万元
仙琚制药最新公告:公司戊酸雌二醇片被批准注册
证券之星 · 07-05
仙琚制药最新公告:公司戊酸雌二醇片被批准注册
仙琚制药(002332.SZ)取得戊酸雌二醇片境内生产药品注册证书
智通财经 · 07-05
仙琚制药(002332.SZ)取得戊酸雌二醇片境内生产药品注册证书
仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书
智通财经 · 07-05
仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书
7月5日仙琚制药涨10.05%,国投瑞银美丽中国混合A基金重仓该股
证券之星 · 07-05
7月5日仙琚制药涨10.05%,国投瑞银美丽中国混合A基金重仓该股
仙琚制药涨10.05%,中泰证券一个月前给出“买入”评级
证券之星 · 07-05
仙琚制药涨10.05%,中泰证券一个月前给出“买入”评级
异动快报:仙琚制药(002332)7月5日14点6分触及涨停板
证券之星 · 07-05
异动快报:仙琚制药(002332)7月5日14点6分触及涨停板
仙琚制药(002332)7月2日主力资金净卖出871.01万元
证券之星 · 07-03
仙琚制药(002332)7月2日主力资金净卖出871.01万元
仙琚制药:截止近期,公司股东人数为2万4千余人
证券之星 · 06-21
仙琚制药:截止近期,公司股东人数为2万4千余人
仙琚制药(002332)6月20日主力资金净买入635.29万元
证券之星 · 06-21
仙琚制药(002332)6月20日主力资金净买入635.29万元
仙琚制药:截止近期,公司股东人数为2万5千余人
证券之星 · 06-04
仙琚制药:截止近期,公司股东人数为2万5千余人
仙琚制药:5月29日接受机构调研,国信证券、华夏久盈等多家机构参与
证券之星 · 05-30
仙琚制药:5月29日接受机构调研,国信证券、华夏久盈等多家机构参与
【机构调研记录】长盛基金调研仙琚制药、灿勤科技
证券之星 · 05-23
【机构调研记录】长盛基金调研仙琚制药、灿勤科技
【机构调研记录】银华基金调研仙琚制药、电投能源等4只个股(附名单)
证券之星 · 05-23
【机构调研记录】银华基金调研仙琚制药、电投能源等4只个股(附名单)
加载更多
公司概况
公司名称:
浙江仙琚制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-01-12
主营业务:
浙江仙琚制药股份有限公司主营业务为甾体原料药和制剂的研制、生产与销售。公司主要产品分为皮质激素类药物、性激素类药物(妇科及计生用药)、麻醉肌松类药物和呼吸科类药物四大类。2023年,在中国医药工业信息中心主办的2023年(第40届)全国医药工业信息年会发布的“2022年度中国医药工业百强榜”中公司位列第70位,同时公司还首次获得“中国医药研发产品线最佳工业企业”“国家企业技术中心”“国家知识产权优势企业”“浙江知识产权示范企业”等诸多荣誉,顺利通过EcoVadis评级荣获银牌勋章。
发行价格:
8.20
{"stockData":{"symbol":"002332","market":"SZ","secType":"STK","nameCN":"仙琚制药","latestPrice":11.81,"timestamp":1721631825000,"preClose":11.49,"halted":0,"volume":11816558,"delay":0,"floatShares":985000000,"shares":989000000,"eps":0.5875,"marketStatus":"已收盘","marketStatusCode":5,"change":0.32,"latestTime":"07-22 15:00:00","open":11.48,"high":11.9,"low":11.39,"amount":138000000,"amplitude":0.0444,"askPrice":11.82,"askSize":269,"bidPrice":11.81,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.5875,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":11.49,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":12.64,"lowLimit":10.34,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":989204866,"pbRate":1.92,"roa":"--","roe":"2.58%","epsLYR":0.57,"committee":-0.853028,"marketValue":11683000000,"floatMarketCap":11628000000,"peRate":20.102128,"changeRate":0.0279,"turnoverRate":0.012,"status":0},"requestUrl":"/m/hq/s/002332","defaultTab":"news","newsList":[{"id":"2453720173","title":"【机构调研记录】财通基金调研仙琚制药、达梦数据等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2453720173","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453720173?lang=zh_cn&edition=full","pubTime":"2024-07-22 08:02","pubTimestamp":1721606562,"startTime":"0","endTime":"0","summary":"财通基金成立于2011年,截至目前,资产管理规模920.23亿元,排名63/204;资产管理规模703.26亿元,排名60/204;管理公募基金数91只,排名70/204;旗下公募基金经理15人,排名87/204。旗下最近一年表现最佳的公募基金产品为财通福佑定开混合发起,最新单位净值为1.55,近一年增长62.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200001645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002332","BK0231","688692","BK0239","SG9999014674.SGD"],"gpt_icon":0},{"id":"2453320120","title":"【机构调研记录】富国基金刘莉莉调研仙琚制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2453320120","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453320120?lang=zh_cn&edition=full","pubTime":"2024-07-22 08:02","pubTimestamp":1721606529,"startTime":"0","endTime":"0","summary":"5)磁谷科技 磁谷科技2024年一季报显示,公司主营收入4366.51万元,同比上升19.83%;归母净利润71.9万元,同比上升158.79%;扣非净利润-370.17万元,同比下降53.49%;负债率29.57%,投资收益29.9万元,财务费用-102.31万元,毛利率33.42%。10)安利股份 个股亮点:公司作为苹果公司合格供应商,主要为苹果公司有关产品及配件指定的代工厂和相关企业提供生态功能性合成革材料。旗下最近一年表现最佳的公募基金产品为富国上海金ETF,最新单位净值为5.41,近一年增长21.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200001597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","BK0028","SG9999014674.SGD"],"gpt_icon":0},{"id":"2452492010","title":"仙琚制药:7月17日接受机构调研,财通基金、富国基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2452492010","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452492010?lang=zh_cn&edition=full","pubTime":"2024-07-19 11:22","pubTimestamp":1721359335,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年7月19日仙琚制药发布公告称公司于2024年7月17日接受机构调研,财通基金张胤 王靖瑄、富国基金李琰 刘莉莉 蒲世林 吕洋楠、广发证券方程嫣、华创证券王宏雨、银华基金薄官辉 吴颖 罗震寰 刘辉 王利刚 陈晓雅 秦锋 岳梅梅 华强强、招商证券许菲菲 侯彪参与。目前该产品销售态势良好。公司正积极开展药品上市相关工作。仙琚制药主营业务:甾体原料药和制剂的研制、","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900022210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"gpt_icon":0},{"id":"2451619877","title":"仙琚制药:截止近期,公司股东人数为2万5千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2451619877","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451619877?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:03","pubTimestamp":1721034236,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)07月15日在投资者关系平台上答复投资者关心的问题。投资者:请问截止7月10号公司股东人数多少?谢谢!仙琚制药董秘:您好!截止近期,公司股东人数为2万5千余人。感谢您的关注。投资者:您好!请问截至7月10号,公司股东人数是多少?谢谢!仙琚制药董秘:您好!截止近期,公司股东人数为2万5千余人。感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500022735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","002332","BK0239"],"gpt_icon":0},{"id":"2450584120","title":"仙琚制药(002332)7月8日主力资金净买入2255.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450584120","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450584120?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:21","pubTimestamp":1720488108,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月8日收盘,仙琚制药报收于11.14元,下跌4.95%,换手率2.35%,成交量23.16万手,成交额2.61亿元。近5日资金流向一览见下表:仙琚制药融资融券信息显示,融资方面,当日融资买入1192.61万元,融资偿还484.63万元,融资净买入707.98万元。仙琚制药主营业务:甾体原料药和制剂的研制、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900014022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","BK0028","SG9999014674.SGD"],"gpt_icon":0},{"id":"2449279750","title":"仙琚制药(002332)7月5日主力资金净买入825.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449279750","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449279750?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:10","pubTimestamp":1720401052,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月5日收盘,仙琚制药报收于11.72元,上涨10.05%,涨停,换手率1.91%,成交量18.8万手,成交额2.13亿元。近5日资金流向一览见下表:仙琚制药融资融券信息显示,融资方面,当日融资买入413.97万元,融资偿还803.81万元,融资净偿还389.84万元。融券方面,融券卖出7.32万股,融券偿还8.79万股,融券余量32.75万股,融券余额383.88万元。仙琚制药主营业务:甾体原料药和制剂的研制、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"gpt_icon":0},{"id":"2449592522","title":"7月5日仙琚制药(002332)龙虎榜数据:机构净买入915.63万元,北向资金净卖出536.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449592522","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449592522?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:12","pubTimestamp":1720170736,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2024年7月5日公布的交易公开信息显示,仙琚制药因日涨幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年7月5日收盘,仙琚制药报收于11.72元,上涨10.05%,涨停,换手率1.91%,成交量18.8万手,成交额2.13亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入915.63万元,北向资金合计净卖出536.35万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500034283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0239","BK0028","SG9999014674.SGD"],"gpt_icon":0},{"id":"2449625926","title":"仙琚制药最新公告:公司戊酸雌二醇片被批准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2449625926","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449625926?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:09","pubTimestamp":1720170579,"startTime":"0","endTime":"0","summary":"仙琚制药公告,公司于近日收到国家药品监督管理局核准签发的关于戊酸雌二醇片的《药品注册证书》(证书编号:2024S01558),公司戊酸雌二醇片被批准注册。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500034172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0028","BK0239","SG9999014674.SGD"],"gpt_icon":0},{"id":"2449225624","title":"仙琚制药(002332.SZ)取得戊酸雌二醇片境内生产药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449225624","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449225624?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:07","pubTimestamp":1720170441,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙琚制药(002332.SZ)发布公告,公司于近日收到国家药品监督管理局核准签发的关于戊酸雌二醇片的《药品注册证书》(证书编号:2024S01558),公司戊酸雌二醇片被批准注册。据悉,戊酸雌二醇最早由德国先灵公司(ScheringAG)研究开发,其制剂戊酸雌二醇片(商品名:补佳乐®/Progynova®)最早于1969年在意大利上市,规格为2mg,用于补充主要与自然或人工绝经相关的雌激素缺乏。1991年Progynova在澳大利亚批准上市,规格1mg和2mg。目前主要在欧洲各国(如:比利时、德国、法国、新西兰、意大利、英国等国家)上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"gpt_icon":0},{"id":"2449244256","title":"仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449244256","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449244256?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:03","pubTimestamp":1720170207,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙琚制药(002332.SZ)发布公告,公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg,批准文号为;国药准字H33020822,目前产品执行标准为《中国药典》2020年版二部。公告称,醋酸地塞米松片被国家药品监督管理局受理,标志着该品种一致性评价工作进入了审评阶段,公司将积极推进后续相关工作,如顺利通过一致性评价将增加其市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","SG9999014674.SGD","BK0028","002332"],"gpt_icon":0},{"id":"2449253832","title":"7月5日仙琚制药涨10.05%,国投瑞银美丽中国混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449253832","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449253832?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:17","pubTimestamp":1720167425,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日仙琚制药涨10.05%,收盘报11.72元,换手率1.91%,成交量18.8万手,成交额2.13亿元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共17家,其中持有数量最多的公募基金为国投瑞银美丽中国混合A。国投瑞银美丽中国混合A目前规模为8.58亿元,最新净值1.003,较上一交易日下跌0.79%,近一年下跌18.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"gpt_icon":0},{"id":"2449538282","title":"仙琚制药涨10.05%,中泰证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2449538282","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449538282?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:16","pubTimestamp":1720167419,"startTime":"0","endTime":"0","summary":"今日仙琚制药涨10.05%,收盘报11.72元。2024年5月13日,中泰证券研究员祝嘉琦发布了对仙琚制药的研报《轻舟已过万重山,开启增长新阶段》,该研报对仙琚制药给出“买入”评级。考虑公司是甾体激素优质赛道原料药制剂一体化龙头,当下进入国内制剂新产品、原料药规范市场的双重共振,迎来新的增长阶段,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为国联证券的夏禹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600918","002332"],"gpt_icon":0},{"id":"2449236617","title":"异动快报:仙琚制药(002332)7月5日14点6分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2449236617","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449236617?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:10","pubTimestamp":1720159830,"startTime":"0","endTime":"0","summary":"证券之星7月5日盘中消息,14点6分仙琚制药触及涨停板。目前价格11.72,上涨10.05%。其所属行业化学制药目前上涨。领涨股为向日葵。该股为创新药,化学原料药,辅助生殖概念热股,当日创新药概念上涨4.09%,化学原料药概念上涨3.59%,辅助生殖概念上涨3.45%。7月4日的资金流向数据方面,主力资金净流出338.2万元,占总成交额2.93%,游资资金净流出2560.66万元,占总成交额22.2%,散户资金净流入2898.86万元,占总成交额25.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500022762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0028","SG9999014674.SGD","BK0239"],"gpt_icon":0},{"id":"2448770117","title":"仙琚制药(002332)7月2日主力资金净卖出871.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448770117","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448770117?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:25","pubTimestamp":1719969919,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月2日收盘,仙琚制药报收于11.15元,下跌2.53%,换手率0.94%,成交量9.3万手,成交额1.04亿元。近5日资金流向一览见下表:仙琚制药融资融券信息显示,融资方面,当日融资买入535.05万元,融资偿还806.24万元,融资净偿还271.19万元。仙琚制药主营业务:甾体原料药和制剂的研制、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300016563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","002332","BK0239"],"gpt_icon":0},{"id":"2445973736","title":"仙琚制药:截止近期,公司股东人数为2万4千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2445973736","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445973736?lang=zh_cn&edition=full","pubTime":"2024-06-21 17:05","pubTimestamp":1718960707,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)06月21日在投资者关系平台上答复投资者关心的问题。投资者:请问截止到2024年6月10日收盘公司股东人数是多少?谢谢仙琚制药董秘:您好!截止近期,公司股东人数为2万4千余人。感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100036746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","BK0028","SG9999014674.SGD"],"gpt_icon":0},{"id":"2445274968","title":"仙琚制药(002332)6月20日主力资金净买入635.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445274968","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445274968?lang=zh_cn&edition=full","pubTime":"2024-06-21 09:13","pubTimestamp":1718932416,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月20日收盘,仙琚制药报收于11.58元,上涨1.22%,换手率1.23%,成交量12.15万手,成交额1.41亿元。近5日资金流向一览见下表:仙琚制药融资融券信息显示,融资方面,当日融资买入1198.22万元,融资偿还709.21万元,融资净买入489.01万元。仙琚制药主营业务:甾体原料药和制剂的研制、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100015492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","SG9999014674.SGD","002332"],"gpt_icon":0},{"id":"2440007734","title":"仙琚制药:截止近期,公司股东人数为2万5千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2440007734","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440007734?lang=zh_cn&edition=full","pubTime":"2024-06-04 18:05","pubTimestamp":1717495507,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)06月04日在投资者关系平台上答复投资者关心的问题。投资者:请问截止5月31日盘后公司登记在册的股东人数是多少?谢谢仙琚制药董秘:您好!截止近期,公司股东人数为2万5千余人。感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060400034970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"gpt_icon":0},{"id":"2439965546","title":"仙琚制药:5月29日接受机构调研,国信证券、华夏久盈等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2439965546","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439965546?lang=zh_cn&edition=full","pubTime":"2024-05-30 10:16","pubTimestamp":1717035418,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年5月30日仙琚制药发布公告称公司于2024年5月29日接受机构调研,国信证券彭思宇、华夏久盈张伟光 周武、交银施罗德徐嘉辰 周章庆、申万菱信姚宏福 张泽平、太平洋医药周豫 乔露阳、浙商证券李千慧、中泰证券祝嘉琪 徐文钰参与。呼吸类产品收入1.8亿元,同比增长28%,主要是糠酸莫米松鼻喷剂收入同比增长。二季度以来,相关产品销售态势良好。仙琚制药主营业务:甾体原料药和制剂的研制、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053000015529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0276","SG9999014674.SGD","BK0028","BK0188","002736","BK0239","002332"],"gpt_icon":0},{"id":"2437269162","title":"【机构调研记录】长盛基金调研仙琚制药、灿勤科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2437269162","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437269162?lang=zh_cn&edition=full","pubTime":"2024-05-23 08:01","pubTimestamp":1716422516,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月22日披露的机构调研信息,长盛基金近期对2家上市公司进行了调研,相关名单如下:1)仙琚制药 个股亮点:控股子公司台州海盛制药,经营范围包括原料药制造;公司非那雄胺片主要用于治疗男性秃发,能促进头发生长并防止继续脱发;主要辅助生殖产品有黄体酮胶囊2)灿勤科技 个股亮点:公司的主要产品在华为5G基站中占据较高市场份额。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052300010454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","SG9999014674.SGD","BK0239","BK0214","002332","688182"],"gpt_icon":0},{"id":"2437226937","title":"【机构调研记录】银华基金调研仙琚制药、电投能源等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2437226937","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437226937?lang=zh_cn&edition=full","pubTime":"2024-05-23 08:01","pubTimestamp":1716422513,"startTime":"0","endTime":"0","summary":"4)灿勤科技 个股亮点:公司的主要产品在华为5G基站中占据较高市场份额。;公司微波介质陶瓷元器件产业链下游主要为移动通信、卫星通讯、卫星导航与定位等领域的产品应用银华基金成立于2001年,截至目前,资产管理规模5603.59亿元,排名18/203;资产管理规模2177.84亿元,排名23/203;管理公募基金数321只,排名18/203;旗下公募基金经理59人,排名14/203。旗下最近一年表现最佳的公募基金产品为银华添泽定开债,最新单位净值为1.81,近一年增长62.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052300010450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0188","002128","BK0010","BK0239","BK0197","BK0266","BK0185","BK0179","002332"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-01-12","address":"浙江省台州市仙居县仙药路1号","stockEarnings":[{"period":"1week","weight":0.0488},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.1114},{"period":"6month","weight":0.1538},{"period":"1year","weight":-0.0294},{"period":"ytd","weight":-0.0522}],"companyName":"浙江仙琚制药股份有限公司","boardCode":"AI0027","perCapita":"39382股","boardName":"医药制造业","registeredCapital":"98920万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 浙江仙琚制药股份有限公司主营业务为甾体原料药和制剂的研制、生产与销售。公司主要产品分为皮质激素类药物、性激素类药物(妇科及计生用药)、麻醉肌松类药物和呼吸科类药物四大类。2023年,在中国医药工业信息中心主办的2023年(第40届)全国医药工业信息年会发布的“2022年度中国医药工业百强榜”中公司位列第70位,同时公司还首次获得“中国医药研发产品线最佳工业企业”“国家企业技术中心”“国家知识产权优势企业”“浙江知识产权示范企业”等诸多荣誉,顺利通过EcoVadis评级荣获银牌勋章。","serverTime":1721668157882,"listedPrice":8.2,"stockholders":"25000人(较上一季度增加4.17%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仙琚制药,002332,仙琚制药股票,仙琚制药股票老虎,仙琚制药股票老虎国际,仙琚制药行情,仙琚制药股票行情,仙琚制药股价,仙琚制药股市,仙琚制药股票价格,仙琚制药股票交易,仙琚制药股票购买,仙琚制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}